» Articles » PMID: 30807744

Ultrastructural Analysis of Submacular Choriocapillaris and Its Transport Systems in AMD and Aged Control Eyes

Overview
Journal Exp Eye Res
Specialty Ophthalmology
Date 2019 Feb 27
PMID 30807744
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The choriocapillaris is the source of nutrients and oxygen for photoreceptors, which consume more oxygen per gram of tissue than any other cell in the body. The purpose of this study was to evaluate and compare the ultrastructure of the choriocapillaris and its transport systems in patients with and without age-related macular degeneration (AMD). Ultrastructural changes were also evaluated in subjects that were homozygous for polymorphisms in high risk CFH alleles (Pure 1) only or homozygous only for high risk ARMS2/HTRA1 (Pure 10) alleles. Tissue samples were obtained from the macular region of forty male (n = 24) and female (n = 16) donor eyes and prepared for ultrastructural studies with transmission electron microscopy (TEM). The average age of the aged donors was 74 ± 7.2 (n = 30) and the young donors 31.7 ± 11.25 (n = 10). There was no significant difference in average ages between the adult groups. TEM images of the capillaries in the choriocapillaris (CC) were taken at 4,000X and 25,000X and used to measure the area of endothelial cell somas, the number of fenestrations, and area of caveolae within the endothelial cells per length of Bruchs membrane (BrMb). The Student t-test and Wilcoxon sum rank test were used to determine significant differences. There was no significant difference between young subjects and aged controls in any of the morphological criteria assessed. There was a significant decrease in the number of fenestrations/mm of BrMb in atrophic areas of GA eyes (p = 0.007) when compared with aged control eyes. A significant increase was found in the caveolae area as a percent of the endothelial cell soma of capillaries from GA subjects as compared with the controls (p = 0.03). Loss of capillary segments in choriocapillaris was also evident, especially in areas of geographic atrophy and CNV. In eyes from patients with sequence variations, the capillary endothelial cells often appeared degenerative and exhibited atypical fenestrations and pericytes covering the blood vessels. Subjects that were homozygous for polymorphisms in high risk CFH alleles only had more fenestrations/mm of BrMb than subjects that were homozygous only for high risk ARMS2/HTRA1 alleles (p = 0.04), while the latter had greater caveolae area/endothelial cell area than the former (p = 0.007). This study demonstrated an attenuation of CC and a significant decline in the two major transport systems in CC endothelial cells in AMD. This may contribute to drusen deposition, nutrient transport, and vision loss in AMD subjects.

Citing Articles

Importance of Choriocapillaris Replacement in Therapeutic Strategies for Age-Related Macular Degeneration.

Burton E, Tovell V, Coffey P Adv Exp Med Biol. 2025; 1468:389-393.

PMID: 39930227 DOI: 10.1007/978-3-031-76550-6_64.


Ghost vessels in the eye: Cell free choriocapillaris domains in atrophic age-related macular degeneration.

Mullins R, Flamme-Wiese M, Navratil E, Boese E, Varzavand K, Riker M Exp Eye Res. 2024; 248:110128.

PMID: 39419369 PMC: 11532014. DOI: 10.1016/j.exer.2024.110128.


The Role of Reactive Oxygen Species in Age-Related Macular Degeneration: A Comprehensive Review of Antioxidant Therapies.

Kulbay M, Wu K, Nirwal G, Belanger P, Tran S Biomedicines. 2024; 12(7).

PMID: 39062152 PMC: 11274723. DOI: 10.3390/biomedicines12071579.


Glial remodeling and choroidal vascular pathology in eyes from two donors with Choroideremia.

Edwards M, McLeod D, Grebe R, Bhutto I, Dahake R, Crumley K Front Ophthalmol (Lausanne). 2024; 2:994566.

PMID: 38983545 PMC: 11182301. DOI: 10.3389/fopht.2022.994566.


Structural OCT and OCT angiography biomarkers associated with the development and progression of geographic atrophy in AMD.

Vallino V, Berni A, Coletto A, Serafino S, Bandello F, Reibaldi M Graefes Arch Clin Exp Ophthalmol. 2024; 262(11):3421-3436.

PMID: 38689123 PMC: 11584504. DOI: 10.1007/s00417-024-06497-8.